Literature DB >> 10592660

Structure and function of the hepatitis C virus NS3-NS4A serine proteinase.

R De Francesco1, C Steinkühler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10592660     DOI： 10.1007/978-3-642-59605-6_8

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN： 0070-217X            Impact factor:   4.291


× No keyword cloud information.
  17 in total

1.  Inhibitor binding induces active site stabilization of the HCV NS3 protein serine protease domain.

Authors:  G Barbato; D O Cicero; F Cordier; F Narjes; B Gerlach; S Sambucini; S Grzesiek; V G Matassa; R De Francesco; R Bazzo
Journal:  EMBO J       Date:  2000-03-15       Impact factor: 11.598

Review 2.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

3.  Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling.

Authors:  Eileen Foy; Kui Li; Rhea Sumpter; Yueh-Ming Loo; Cynthia L Johnson; Chunfu Wang; Penny Mar Fish; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

4.  Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.

Authors:  Kui Li; Eileen Foy; Josephine C Ferreon; Mitsuyasu Nakamura; Allan C M Ferreon; Masanori Ikeda; Stuart C Ray; Michael Gale; Stanley M Lemon
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  Effect of pegylated interferon on non-responders and relapsers with interferon.

Authors:  Hisham O Akbar; Mahmoud S Al Ahwal
Journal:  J Sci Res Med Sci       Date:  2002-04

6.  Development of cell-based assays for in vitro characterization of hepatitis C virus NS3/4A protease inhibitors.

Authors:  Victoria Chung; Anthony R Carroll; Norman M Gray; Nigel R Parry; Pia A Thommes; K Claire Viner; Eric A D'Souza
Journal:  Antimicrob Agents Chemother       Date:  2005-04       Impact factor: 5.191

7.  Establishment of a simple assay in vitro for hepatitis C virus NS3 serine protease based on recombinant substrate and single-chain protease.

Authors:  Gui-Xin Du; Li-Hua Hou; Rong-Bin Guan; Yi-Gang Tong; Hai-Tao Wang
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

8.  Isolation of specific and high-affinity RNA aptamers against NS3 helicase domain of hepatitis C virus.

Authors:  Byounghoon Hwang; Jung Sun Cho; Hyeon Ju Yeo; Jung-Hye Kim; Kyung Min Chung; Kyungsook Han; Sung Key Jang; Seong-Wook Lee
Journal:  RNA       Date:  2004-07-09       Impact factor: 4.942

9.  Psammaplin A inhibits hepatitis C virus NS3 helicase.

Authors:  Kazi Abdus Salam; Atsushi Furuta; Naohiro Noda; Satoshi Tsuneda; Yuji Sekiguchi; Atsuya Yamashita; Kohji Moriishi; Masamichi Nakakoshi; Masayoshi Tsubuki; Hidenori Tani; Junichi Tanaka; Nobuyoshi Akimitsu
Journal:  J Nat Med       Date:  2013-01-29       Impact factor: 2.343

10.  Structural determinants for membrane association and dynamic organization of the hepatitis C virus NS3-4A complex.

Authors:  Volker Brass; Jan Martin Berke; Roland Montserret; Hubert E Blum; François Penin; Darius Moradpour
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-17       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.